Sign in

    Thomas A. Fitzgerald

    Interim Chief Executive Officer at Transcode Therapeutics Inc
    Since January 13, 2024
    Age
    74 years
    Education
    Holds an A.B. in Economics with Honors from Stanford University and an M.B.A. from the Harvard University Graduate School of Business Administration.
    Tenure
    Joined RNAZ in 07-2018 as Vice President, Chief Financial Officer, and Director and was promoted to Interim Chief Executive Officer on 01-13-2024.

    Also at Transcode Therapeutics Inc

    No other executives available

    About

    Thomas A. Fitzgerald is a seasoned executive with extensive experience in finance and leadership within the life sciences industry. He served in the U.S. Army as an airborne-qualified infantry officer and has built a solid foundation through his military service, which underscores his discipline and leadership qualities.

    He holds strong academic credentials, having earned an A.B. in Economics with Honors from Stanford University and an M.B.A. from the Harvard University Graduate School of Business Administration, which have been key contributors to his professional achievements.

    During his tenure at RNAZ, he joined in July 2018 as Vice President, Chief Financial Officer, and Director, later transitioning to a full-time role and being promoted to Interim Chief Executive Officer on January 13, 2024. His leadership in these roles has been integral in steering the company's financial and strategic direction.

    $RNAZ Performance Under Thomas A. Fitzgerald

    Past Roles

    OrganizationRoleDate RangeDetails
    TransCode Therapeutics, Inc. (RNAZ) Chief Financial Officer N/A Held prior to becoming Interim Chief Executive Officer

    Fixed Compensation

    Data from  FY 2023
    Component NameAmountPayment ScheduleAdditional Details
    Salary $382,000 (base salary; adjusted to $358,138 after reduction for three pay periods) N/A [N/A]Voluntary reduction in three pay periods; approximately 3% annual increase observed
    Option Awards $68,724 N/A [N/A]Represents the aggregate grant-date fair value calculated under FASB ASC Topic 718; does not reflect actual economic value

    Performance Compensation

    Data from  FY 2023

    No information available on performance compensation for 2023